100 results
DEFA14A
SAGE
Sage Therapeutics Inc
24 Apr 24
Additional proxy soliciting materials
4:10pm
the compensation paid to our named executive officers. For 4. To approve the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. For NOTE: To transact
SC TO-I/A
SAGE
Sage Therapeutics Inc
27 Mar 24
Issuer tender offer statement (amended)
4:09pm
of the Company’s common stock, pursuant to the terms of the Offer to Exchange and the 2014 Stock Option and Incentive Plan. The exercise price per share
SC TO-I/A
SAGE
Sage Therapeutics Inc
21 Feb 24
Issuer tender offer statement (amended)
4:35pm
shares of the Company’s common stock, pursuant to the terms of the Offer to Exchange and the 2014 Stock Option and Incentive Plan. The exercise price
S-8
ugnpan h6fg
14 Feb 24
Registration of securities for employees
7:49am
S-8
EX-5.1
y845jx29
14 Feb 24
Registration of securities for employees
7:49am
SC TO-I/A
ukffvodnvocrna4q9
31 Jan 24
Issuer tender offer statement (amended)
5:25pm
SC TO-I
EX-99
ouuv2kz
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
EX-99
xkrk50925 o7mt3dkv6
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
EX-99
7n9iui n6w5o1y6gs95
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
EX-99
xtk33tgtnl 8n
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
i0pe2ps9
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
EX-99
1nxma7whe
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
EX-99
n2hecteh918 4tn
23 Jan 24
Issuer tender offer statement
8:13am
PRE 14A
unu18vkh9uaptmd4p
8 Dec 23
Preliminary proxy
8:30am
8-K
EX-1.1
pb12dz3d tf8
7 Nov 23
Entry into a Material Definitive Agreement
7:39am